Synthetic strategy and structure–activity relationship (SAR) studies of 3-(5′-hydroxymethyl-2′-furyl)-1-benzyl indazole (YC-1, Lificiguat): a review
Keyword(s):
Since 1994, YC-1 (Lificiguat) has been synthesized, and many targets for special bioactivities have been explored, such as stimulation of platelet-soluble guanylate cyclase, indirect elevation of platelet cGMP levels, and inhibition of HIF-1 and NF-κB.
2015 ◽
Vol 89
◽
pp. 21-31
◽
2016 ◽
Vol 111
◽
pp. 138-159
◽
Keyword(s):
2018 ◽
Vol 16
(42)
◽
pp. 7833-7842
◽
2011 ◽
Vol 19
(7)
◽
pp. 2269-2281
◽
2018 ◽
Vol 61
(4)
◽
pp. 1688-1703
◽
Keyword(s):
2021 ◽
Vol 209
◽
pp. 112886
2001 ◽
Vol 49
(4)
◽
pp. 353-360
◽
2015 ◽
Vol 58
(23)
◽
pp. 9258-9272
◽
Keyword(s):